Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GANAB | Q14697 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 3/20 | 0.41 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20530466 | 0.73 | — | — | |
| SCHEMBL20016785 | 0.73 | — | — | |
| SCHEMBL20530484 | 0.73 | — | — | |
| SCHEMBL13575911 | 0.73 | — | — | |
| SCHEMBL20631996 | 0.73 | GBA1 (0.47) | GANABGBA1 | |
| SCHEMBL20530492 | 0.73 | — | — | |
| SCHEMBL20530436 | 0.73 | — | — | |
| SCHEMBL14767829 | 0.70 | — | — | |
| SCHEMBL9868405 | 0.67 | FUCA1 (0.38) | GBA1 | |
| SCHEMBL24547699 | 0.65 | GAA (0.56) | GANABGBA1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015793-A1 | Synthesis of nojirimycins | MACROZYME DNM B.V. (NL) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015793-A1 | Synthesis of nojirimycins | DHPS, NOS1, MRM1 | GANAB 463/4885GBA1 1280/4885MGAM 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.